A clinical study for TBP-101 (CHDF hemofilter)

A clinical study for TBP-101 (CHDF hemofilter) - A clinical study for TBP-101 (CHDF hemofilter)

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000028674

Enrollment

Registered

2017-08-15

Start date

2017-07-25

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Kidney Injury

Interventions

Perform CRRT by using TBP-101 for 24 hours or more per device.Use 3 investigational devices per patient.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1)Patients who are 20 and over, and under 80. 2)Patients diagnosed with acute kidney injury by using KDIGO definition within 2 days before the first consent.

Exclusion criteria

Exclusion criteria: 1)Patients with disease hard to be treated by CRRT, such as Heparin-Induced Thrombocytopenia (HIT). 2)Patients with anamnesis of allergy symptoms such as anaphylaxis caused by dialyzer, hemofilter et al.

Design outcomes

Primary

Measure	Time frame
1)Average hours the investigational device is used 2)Adverse events 3)Device deficiencies	—

Countries

Japan

Contacts

Public ContactChihiro Ishizuka

Toray Industries, Inc. Clinical Data Science & Quality Management Dept.

Chihiro_Ishizuka@nts.toray.co.jp03-3245-8588

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026